Prevention of diabetes mellitus type 2. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Islets of Langerhans Insulin-Secreting Cells Pancreas Venoms Kidney Liver Endothelium, Vascular

Organisms6

Mice, Inbred NOD Rats, Inbred BB Rats, Wistar Rats, Zucker Rats, Sprague-Dawley Rats, Inbred OLETF

Diseases45

Diabetes Mellitus, Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus Diabetic Neuropathies Diabetic Nephropathies Obesity Diabetes Complications Diabetes Mellitus, Experimental Diabetes, Gestational Hyperglycemia Diabetic Angiopathies Insulin Resistance Diabetic Retinopathy Pregnancy in Diabetics Diabetic Ketoacidosis Cardiovascular Diseases Hypertension Prediabetic State Glucose Intolerance Hypoglycemia Diabetes Insipidus Albuminuria Metabolic Syndrome X Body Weight Coronary Artery Disease Genetic Predisposition to Disease Dyslipidemias Diabetic Foot Hyperlipidemias Coronary Disease Glycosuria Kidney Failure, Chronic Disease Models, Animal Disease Progression Stroke Chronic Disease Myocardial Infarction Wolfram Syndrome Atherosclerosis Weight Loss Hyperinsulinism Diabetes Mellitus, Lipoatrophic Diabetic Cardiomyopathies HIV Infections Hypercholesterolemia

Chemicals and Drugs37

Hypoglycemic Agents Blood Glucose Hemoglobin A, Glycosylated Insulin Streptozocin Metformin Sulfonylurea Compounds Glucose C-Peptide Biological Markers Glutamate Decarboxylase Thiazolidinediones Alloxan Lipids Triglycerides Fructosamine Dipeptidyl-Peptidase IV Inhibitors Glucagon-Like Peptide 1 Autoantibodies Islet Amyloid Polypeptide Proinsulin Antihypertensive Agents Glucagon Cholesterol Cholesterol, LDL Adiponectin Cholesterol, HDL Hypolipidemic Agents Creatinine Incretins Venoms Hydroxymethylglutaryl-CoA Reductase Inhibitors Glycosylation End Products, Advanced HLA-DQ Antigens Adamantane C-Reactive Protein HLA-DQ beta-Chains

Analytical, Diagnostic and Therapeutic Techniques and Equipment51

Case-Control Studies Risk Factors Obesity Diabetes Mellitus, Experimental Glucose Tolerance Test Prevalence Incidence Body Mass Index Prospective Studies Follow-Up Studies Cohort Studies Treatment Outcome Retrospective Studies Risk Assessment Cross-Sectional Studies Blood Glucose Self-Monitoring Blood Pressure Diabetic Diet Multivariate Analysis Logistic Models Body Weight Odds Ratio Questionnaires Reference Values Regression Analysis Insulin Infusion Systems Proportional Hazards Models Predictive Value of Tests Chi-Square Distribution Self Care Risk Disease Models, Animal Analysis of Variance Randomized Controlled Trials as Topic Mass Screening Glucose Clamp Technique Double-Blind Method Severity of Illness Index Drug Therapy, Combination Islets of Langerhans Transplantation Longitudinal Studies Prognosis Glomerular Filtration Rate Confidence Intervals Registries Pilot Projects Linear Models Health Surveys Pancreas Transplantation Administration, Oral Program Evaluation

Psychiatry and Psychology6

Fasting Life Style Smoking Risk Reduction Behavior Health Knowledge, Attitudes, Practice Patient Compliance

Phenomena and Processes26

Obesity Insulin Resistance Body Mass Index Time Factors Pregnancy Fasting Blood Pressure Diabetic Diet Body Weight Odds Ratio Genetic Predisposition to Disease Chi-Square Distribution Risk Genotype Diet Postprandial Period Oxidative Stress Exercise Glomerular Filtration Rate Weight Loss Polymorphism, Single Nucleotide Polymorphism, Genetic Aging Glycemic Index Alleles Dose-Response Relationship, Drug

Disciplines and Occupations1

Anthropology, Education, Sociology and Social Phenomena6

Centers for Disease Control and Prevention (U.S.)Patient Education as Topic Sex Distribution Age Distribution Exercise Socioeconomic Factors

Technology, Industry, Agriculture1

Information Science4

Prevalence Incidence Questionnaires Registries

Named Groups6

Asian Continental Ancestry Group Indians, North American Infant, Newborn African Continental Ancestry Group African Americans Hispanic Americans

Health Care53

Case-Control Studies Risk Factors Prevalence Primary Prevention Incidence Body Mass Index Prospective Studies Follow-Up Studies Cohort Studies Treatment Outcome Retrospective Studies Risk Assessment Cross-Sectional Studies Age Factors Comorbidity Multivariate Analysis Sex Factors Secondary Prevention Logistic Models Centers for Disease Control and Prevention (U.S.)Odds Ratio Questionnaires Regression Analysis Proportional Hazards Models Predictive Value of Tests Chi-Square Distribution Self Care Risk Patient Education as Topic Sex Distribution Analysis of Variance Randomized Controlled Trials as Topic Mass Screening Disease Management Age Distribution Double-Blind Method Severity of Illness Index Accident Prevention Longitudinal Studies Health Knowledge, Attitudes, Practice Practice Guidelines as Topic Confidence Intervals Patient Compliance Age of Onset Health Promotion Registries Pilot Projects Linear Models Health Surveys Primary Health Care Glycemic Index Socioeconomic Factors Program Evaluation

Geographicals6

United States Japan China Arizona India Netherlands

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Diabetes Mellitus, Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus Hypoglycemic Agents Blood Glucose Diabetic Neuropathies Hemoglobin A, Glycosylated Diabetic Nephropathies Insulin Case-Control Studies Risk Factors Obesity Diabetes Complications Diabetes Mellitus, Experimental Diabetes, Gestational Hyperglycemia Glucose Tolerance Test Diabetic Angiopathies Prevalence Insulin Resistance Primary Prevention Diabetic Retinopathy Islets of Langerhans Streptozocin Pregnancy in Diabetics Incidence Body Mass Index Diabetic Ketoacidosis Prospective Studies Follow-Up Studies Cardiovascular Diseases Hypertension Time Factors Cohort Studies Prediabetic State Glucose Intolerance Treatment Outcome Hypoglycemia Retrospective Studies Metformin United States Sulfonylurea Compounds Insulin-Secreting Cells Risk Assessment Glucose Diabetes Insipidus Cross-Sectional Studies Blood Glucose Self-Monitoring Pregnancy C-Peptide Albuminuria Biological Markers Fasting Age Factors Comorbidity Glutamate Decarboxylase Blood Pressure Diabetic Diet Multivariate Analysis Sex Factors Secondary Prevention Mice, Inbred NOD Logistic Models Metabolic Syndrome X Centers for Disease Control and Prevention (U.S.)Rats, Inbred BB Body Weight Thiazolidinediones Odds Ratio Questionnaires Japan Alloxan Reference Values Lipids Life Style Regression Analysis Coronary Artery Disease Genetic Predisposition to Disease Insulin Infusion Systems Triglycerides Fructosamine Dyslipidemias Diabetic Foot Dipeptidyl-Peptidase IV Inhibitors Proportional Hazards Models Hyperlipidemias Predictive Value of Tests Pancreas Chi-Square Distribution Self Care Risk Glucagon-Like Peptide 1 Coronary Disease Asian Continental Ancestry Group Glycosuria Kidney Failure, Chronic Indians, North American Disease Models, Animal Genotype Patient Education as Topic

No FAQ available that match "prevention of diabetes mellitus type 2"